Literature DB >> 19392745

Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings.

Purnima Madhivanan1, Karl Krupp, Jill Hardin, Chitra Karat, Jeffrey D Klausner, Arthur L Reingold.   

Abstract

OBJECTIVE: Bacterial vaginosis (BV) and Trichomonas vaginalis infection (TV) have been associated with adverse birth outcomes and increased risk for HIV. We compare the performance of simple inexpensive point-of-care (POC) tests to laboratory diagnosis and syndromic management of BV and TV in poor settings.
METHODS: Between November 2005 and March 2006, 898 sexually active women attending two reproductive health clinics in Mysore, India were recruited into a cohort study investigating the relationship between vaginal flora and HSV-2 infection. Participants were interviewed and screened for reproductive tract infections. Laboratory tests included serology for HSV-2; cultures for TV, Candida sp., and Neisseria gonorrhoeae; Gram stains; and two POC tests: vaginal pH; and Whiff test.
RESULTS: Of the 898 participants, 411 [45.7%, 95% confidence interval (95% CI): 42.4-49.0%] had any laboratory diagnosed vaginal infection. BV was detected in 165 women (19.1%, 95%CI: 16.5-21.9%) using Nugent score. TV was detected in 76 women (8.5%, 95%CI: 6.7-10.4%) using culture. Among the entire study population, POC correctly detected 82% of laboratory diagnosed BV cases, and 83% of laboratory diagnosed TV infections. Among women with complaints of vulval itching, burning, abnormal vaginal discharge, and/or sores (445/898), POC correctly detected 83% (60 of 72 cases) of laboratory diagnosed BV cases vs. 40% (29 of 72 cases) correctly managed using the syndromic approach (P < 0.001). Similarly, POC would have detected 82% (37 of 45 cases) of TV cases vs. 51% (23 of 45 cases) correctly managed using the syndromic approach (P = 0.001).
CONCLUSIONS: In the absence of laboratory diagnostics, POC is not only inexpensive and practical, but also significantly more sensitive than the syndromic management approach, resulting in less overtreatment. .

Entities:  

Mesh:

Year:  2009        PMID: 19392745      PMCID: PMC3625926          DOI: 10.1111/j.1365-3156.2009.02274.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  24 in total

1.  Syndromic management of vaginal discharge among women in a reproductive health clinic in India.

Authors:  S Vishwanath; V Talwar; R Prasad; K Coyaji; C J Elias; I de Zoysa
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Marginal validity of syndromic management for reproductive tract infections among pregnant women in Jamaica.

Authors:  T Hylton-Kong; A R Brathwaite; G R Del Rosario; S Kristensen; P Kamara; P E Jolly; E W Hook; J P Figueroa; S H Vermund
Journal:  Int J STD AIDS       Date:  2004-06       Impact factor: 1.359

3.  Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India.

Authors:  S Panchanadeswaran; S C Johnson; K H Mayer; A K Srikrishnan; S Sivaran; C E Zelaya; V F Go; S Solomon; M E Bentley; D D Celentano
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

4.  The burden and determinants of reproductive tract infections in India: a population based study of women in Goa, India.

Authors:  V Patel; H A Weiss; D Mabey; B West; S D'Souza; V Patil; P Nevrekar; S Gupte; B R Kirkwood
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

5.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

6.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

7.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

9.  Genital flora in pregnancy and its association with intrauterine growth retardation.

Authors:  M Germain; M A Krohn; S L Hillier; D A Eschenbach
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.

Authors:  S L Hillier; R P Nugent; D A Eschenbach; M A Krohn; R S Gibbs; D H Martin; M F Cotch; R Edelman; J G Pastorek; A V Rao
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more
  17 in total

Review 1.  Syndromic Diagnosis in Evaluation of Women with Symptoms of Vaginitis.

Authors:  Theophilus Ogochukwu Nwankwo; Uzochukwu Uzoma Aniebue; Uchenna Anthony Umeh
Journal:  Curr Infect Dis Rep       Date:  2017-01       Impact factor: 3.725

2.  Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa.

Authors:  Koleka Mlisana; Nivashnee Naicker; Lise Werner; Lindi Roberts; Francois van Loggerenberg; Cheryl Baxter; Jo-Ann S Passmore; Anneke C Grobler; A Willem Sturm; Carolyn Williamson; Katharina Ronacher; Gerhard Walzl; Salim S Abdool Karim
Journal:  J Infect Dis       Date:  2012-04-19       Impact factor: 5.226

3.  Rapid Antigen Testing for Trichomoniasis in an Emergency Department.

Authors:  Nikki R Postenrieder; Jennifer L Reed; Elizabeth Hesse; Jessica A Kahn; Lili Ding; Charlotte A Gaydos; Anne Rompalo; Lea E Widdice
Journal:  Pediatrics       Date:  2016-06       Impact factor: 7.124

4.  Evaluating the utility of syndromic case management for three sexually transmitted infections in women visiting hospitals in Delhi, India.

Authors:  Subash Chandra Sonkar; Kirti Wasnik; Anita Kumar; Vineeta Sharma; Pratima Mittal; Prashant Kumar Mishra; Mausumi Bharadwaj; Daman Saluja
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

5.  High prevalence of curable sexually transmitted infections among pregnant women in a rural county hospital in Kilifi, Kenya.

Authors:  Simon Chengo Masha; Elizabeth Wahome; Mario Vaneechoutte; Piet Cools; Tania Crucitti; Eduard J Sanders
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

6.  Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India.

Authors:  Sujit D Rathod; Jeffrey D Klausner; Karl Krupp; Arthur L Reingold; Purnima Madhivanan
Journal:  Infect Dis Obstet Gynecol       Date:  2012-10-15

7.  Logic regression-derived algorithms for syndromic management of vaginal infections.

Authors:  Sujit D Rathod; Tan Li; Jeffrey D Klausner; Alan Hubbard; Arthur L Reingold; Purnima Madhivanan
Journal:  BMC Med Inform Decis Mak       Date:  2015-12-16       Impact factor: 2.796

8.  Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.

Authors:  Baljinder Kaur; Praveen P Balgir; Bharti Mittu; Balvir Kumar; Neena Garg
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

9.  Performance of BVBlue rapid test in detecting bacterial vaginosis among women in Mysore, India.

Authors:  Purnima Madhivanan; Karl Krupp; Tan Li; Kavitha Ravi; Julia Selezneva; Vijaya Srinivas; Anjali Arun; Jeffrey D Klausner
Journal:  Infect Dis Obstet Gynecol       Date:  2014-01-12

10.  Trichomonas vaginalis PREVALENCE AND RISK FACTORS FOR WOMEN IN SOUTHERN BRAZIL.

Authors:  Cíntia Lima Ambrozio; Andréia Saggin Nagel; Sabrina Jeske; Guilherme Cassão Marques Bragança; Sibele Borsuk; Marcos Marreiro Villela
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.